Literature DB >> 32170587

Postoperative management of patients with pituitary tumors submitted to pituitary surgery. Experience of a Spanish Pituitary Tumor Center of Excellence.

M Araujo-Castro1,2, E Pascual-Corrales3, J S Martínez San Millan4, G Rebolleda5,6, H Pian7, I Ruz-Caracuel7, G De Los Santos Granados6,8,9, L Ley Urzaiz10, H F Escobar-Morreale3,6,9,11, V Rodríguez Berrocal10.   

Abstract

There is a lack of evidence on timing, frequency, and duration of postoperative endocrine, radiologic, and ophthalmologic assessments that should be performed after pituitary surgery (PS). However, it is known that careful optimization of treatment and follow-up strategies as well as a multidisciplinary approach may have a significant impact on long-term outcomes, improving surgical results, minimize complications and facilitate their correct treatment if occurring, and optimize the hormonal, ophthalmological, and radiological reassessment throughout the follow-up. Considering that there are no specific guidelines on the postoperative management of patients with pituitary tumors (PT), we present our protocol for the postoperative management of patients with PT. It has been elaborated by the multidisciplinary team of a Spanish Pituitary Tumor Center of Excellence (PTCE) that includes at least one neurosurgeon, ENT, neuroradiologist, neuro-ophthalmologist, endocrine pathologist and endocrinologist specialized in pituitary diseases. We elaborated this guideline with the aim of sharing our experience with other centers involved in the management of PT thereby facilitating the postoperative management of patients submitted to PS.

Entities:  

Keywords:  Adrenal insufficiency; Diabetes insipidus; Glucocorticoid; Hypopituitarism; Pituitary surgery; Pituitary tumors

Mesh:

Year:  2020        PMID: 32170587     DOI: 10.1007/s12020-020-02247-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  10 in total

1.  Effect of pituitary adenoma consistency on surgical outcomes in patients undergoing endonasal endoscopic transsphenoidal surgery.

Authors:  A Acitores Cancela; V Rodríguez Berrocal; H Pian Arias; J J Díez; P Iglesias
Journal:  Endocrine       Date:  2022-08-13       Impact factor: 3.925

2.  Novel Nomograms to Predict Delayed Hyponatremia After Transsphenoidal Surgery for Pituitary Adenoma.

Authors:  Kunzhe Lin; Ran Zeng; Shuwen Mu; Yinghong Lin; Shousen Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

3.  Presurgical somatostatin receptor ligand treatment does not affect tumor consistency in GH-secreting pituitary macroadenomas.

Authors:  Marta Araujo-Castro; Héctor Pian; Ignacio Ruz-Caracuel; Alberto Acitores Cancela; Eider Pascual-Corrales; Víctor Rodríguez Berrocal
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

4.  Perioperative Management of a Patient With Cushing Disease.

Authors:  Elena V Varlamov; Greisa Vila; Maria Fleseriu
Journal:  J Endocr Soc       Date:  2022-01-28

5.  Radiological Knosp, Revised-Knosp, and Hardy-Wilson Classifications for the Prediction of Surgical Outcomes in the Endoscopic Endonasal Surgery of Pituitary Adenomas: Study of 228 Cases.

Authors:  Marta Araujo-Castro; Alberto Acitores Cancela; Carlos Vior; Eider Pascual-Corrales; Víctor Rodríguez Berrocal
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

Review 6.  Conceptualising centres of excellence: a scoping review of global evidence.

Authors:  Tsegahun Manyazewal; Yimtubezinash Woldeamanuel; Claire Oppenheim; Asrat Hailu; Mirutse Giday; Girmay Medhin; Anteneh Belete; Getnet Yimer; Asha Collins; Eyasu Makonnen; Abebaw Fekadu
Journal:  BMJ Open       Date:  2022-02-07       Impact factor: 2.692

7.  Risk factors for delayed postoperative hyponatremia in patients with non-functioning pituitary adenomas undergoing transsphenoidal surgery: A single-institution study.

Authors:  Yinxing Huang; Meina Wang; Jianwu Wu; Kunzhe Lin; Shousen Wang; Fangfang Zhang
Journal:  Front Neurol       Date:  2022-07-19       Impact factor: 4.086

8.  Is it possible to predict the development of diabetes insipidus after pituitary surgery? Study of 241 endoscopic transsphenoidal pituitary surgeries.

Authors:  M Araujo-Castro; F Mariño-Sánchez; A Acitores Cancela; A García Fernández; S García Duque; V Rodríguez Berrocal
Journal:  J Endocrinol Invest       Date:  2020-10-11       Impact factor: 4.256

9.  Improvement in the Quality of Early Postoperative Course After Endoscopic Transsphenoidal Pituitary Surgery: Description of Surgical Technique and Outcome.

Authors:  Xinfa Pan; Yuehui Ma; Minwei Fang; Jiajing Jiang; Jie Shen; Renya Zhan
Journal:  Front Neurol       Date:  2020-10-20       Impact factor: 4.003

Review 10.  Postoperative diabetes insipidus: how to define and grade this complication?

Authors:  Friso de Vries; Daniel J Lobatto; Marco J T Verstegen; Wouter R van Furth; Alberto M Pereira; Nienke R Biermasz
Journal:  Pituitary       Date:  2020-09-29       Impact factor: 4.107

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.